Emerging Landscape of Cell-Penetrating Peptide-Mediated Organelle Restoration and Replacement

Overview

Journal ACS Pharmacol Transl Sci

Publisher American Chemical Society

Specialty Biochemistry

Date 2023 Feb 17

PMID 36798470

Authors

Jingping Geng

Jing Wang

Hu Wang

Affiliations

Soon will be listed here.

Abstract

Organelles are specialized subunits within a cell membrane that perform specific roles or functions, and their dysfunction can lead to a variety of pathophysiologies including developmental defects, aging, and diseases (cancer, cardiovascular and neurodegenerative diseases). Recent studies have shown that cell-penetrating peptide (CPP)-based pharmacological therapies delivered to organelles or even directly resulting in organelle replacement can restore cell function and improve or prevent disease. In this review, we summarized the current developments in the precise delivery of exogenous cargoes via CPPs at the organelle level, CPP-mediated organelle delivery, and discuss their feasibility as next-generation targeting strategies for the diagnosis and treatment of diseases at the organelle level.

Citing Articles

Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition.

Lo Y, Hong C, Wang C, Yang C Arch Pharm Res. 2024; 47(10-11):829-853.

PMID: 39482441 PMC: 11602847. DOI: 10.1007/s12272-024-01514-0.

Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies.

Wang J, Zhang M, Wang H ACS Pharmacol Transl Sci. 2024; 7(8):2306-2325.

PMID: 39144566 PMC: 11320744. DOI: 10.1021/acsptsci.4c00284.

Emerging Landscape of Supercharged Proteins and Peptides for Drug Delivery.

Wang L, Geng J, Wang H ACS Pharmacol Transl Sci. 2024; 7(3):614-629.

PMID: 38481692 PMC: 10928892. DOI: 10.1021/acsptsci.3c00397.

Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.

Sun Y, Li L, Wang J, Liu H, Wang H ACS Pharmacol Transl Sci. 2024; 7(1):72-96.

PMID: 38230285 PMC: 10789133. DOI: 10.1021/acsptsci.3c00324.

Delivery of Oleanolic Acid with Improved Antifibrosis Efficacy by a Cell Penetrating Peptide P10.

Wang L, Geng J, Wang H ACS Pharmacol Transl Sci. 2023; 6(7):1006-1014.

PMID: 37470025 PMC: 10353059. DOI: 10.1021/acsptsci.3c00087.

References

Carelli V, Chan D . Mitochondrial DNA: impacting central and peripheral nervous systems. Neuron. 2014; 84(6):1126-42. PMC: 4271190. DOI: 10.1016/j.neuron.2014.11.022. View

Li X, Ma L, Fu P . The Mitochondrion-Targeted Antioxidants in Kidney Disease. Curr Med Chem. 2020; 28(21):4190-4206. DOI: 10.2174/0929867327666201020151124. View

Lalonde M, Durocher Y . Therapeutic glycoprotein production in mammalian cells. J Biotechnol. 2017; 251:128-140. DOI: 10.1016/j.jbiotec.2017.04.028. View

Spivak M, Bubnov R, Yemets I, Lazarenko L, Tymoshok N, Ulberg Z . Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology. EPMA J. 2013; 4(1):20. PMC: 3751918. DOI: 10.1186/1878-5085-4-20. View

He L, Lu J, Yue Z . Autophagy in ageing and ageing-associated diseases. Acta Pharmacol Sin. 2013; 34(5):605-11. PMC: 3647216. DOI: 10.1038/aps.2012.188. View

Iwasaki T, Tokuda Y, Kotake A, Okada H, Takeda S, Kawano T . Cellular uptake and in vivo distribution of polyhistidine peptides. J Control Release. 2015; 210:115-24. DOI: 10.1016/j.jconrel.2015.05.268. View

Valdor R, Macian F . Autophagy and the regulation of the immune response. Pharmacol Res. 2012; 66(6):475-83. PMC: 3508673. DOI: 10.1016/j.phrs.2012.10.003. View

Chang J, Liu K, Chuang C, Su H, Wei Y, Kuo S . Treatment of human cells derived from MERRF syndrome by peptide-mediated mitochondrial delivery. Cytotherapy. 2013; 15(12):1580-96. DOI: 10.1016/j.jcyt.2013.06.008. View

Taguchi T, Mukai K, Takaya E, Shindo R . STING Operation at the ER/Golgi Interface. Front Immunol. 2021; 12:646304. PMC: 8126659. DOI: 10.3389/fimmu.2021.646304. View

10.

Gurke S, Barroso J, Hodneland E, Bukoreshtliev N, Schlicker O, Gerdes H . Tunneling nanotube (TNT)-like structures facilitate a constitutive, actomyosin-dependent exchange of endocytic organelles between normal rat kidney cells. Exp Cell Res. 2008; 314(20):3669-83. DOI: 10.1016/j.yexcr.2008.08.022. View

11.

Chang J, Chao Y, Chang H, Wu Y, Chang H, Lin Y . Intranasal delivery of mitochondria for treatment of Parkinson's Disease model rats lesioned with 6-hydroxydopamine. Sci Rep. 2021; 11(1):10597. PMC: 8136477. DOI: 10.1038/s41598-021-90094-w. View

12.

Hou S, Yang Y, Zhou S, Kuang X, Yang Y, Gao H . Novel SS-31 modified liposomes for improved protective efficacy of minocycline against drug-induced hearing loss. Biomater Sci. 2018; 6(6):1627-1635. DOI: 10.1039/c7bm01181d. View

13.

Wilson D, Cate J . The structure and function of the eukaryotic ribosome. Cold Spring Harb Perspect Biol. 2012; 4(5). PMC: 3331703. DOI: 10.1101/cshperspect.a011536. View

14.

Xu H, Liao C, Liang S, Ye B . A Novel Peptide-Equipped Exosomes Platform for Delivery of Antisense Oligonucleotides. ACS Appl Mater Interfaces. 2021; 13(9):10760-10767. DOI: 10.1021/acsami.1c00016. View

15.

Espejo-Mojica A, Almeciga-Diaz C, Rodriguez A, Mosquera A, Diaz D, Beltran L . Human recombinant lysosomal enzymes produced in microorganisms. Mol Genet Metab. 2015; 116(1-2):13-23. DOI: 10.1016/j.ymgme.2015.06.001. View

16.

Diao Y, Wang G, Zhu B, Li Z, Wang S, Yu L . Loading of "cocktail siRNAs" into extracellular vesicles via TAT-DRBD peptide for the treatment of castration-resistant prostate cancer. Cancer Biol Ther. 2022; 23(1):163-172. PMC: 8855870. DOI: 10.1080/15384047.2021.2024040. View

17.

Shteinfer-Kuzmine A, Amsalem Z, Arif T, Zooravlov A, Shoshan-Barmatz V . Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy. Mol Oncol. 2018; 12(7):1077-1103. PMC: 6026870. DOI: 10.1002/1878-0261.12313. View

18.

Gabelein C, Feng Q, Sarajlic E, Zambelli T, Guillaume-Gentil O, Kornmann B . Mitochondria transplantation between living cells. PLoS Biol. 2022; 20(3):e3001576. PMC: 8942278. DOI: 10.1371/journal.pbio.3001576. View

19.

Wu J, Li J, Wang H, Liu C . Mitochondrial-targeted penetrating peptide delivery for cancer therapy. Expert Opin Drug Deliv. 2018; 15(10):951-964. DOI: 10.1080/17425247.2018.1517750. View

20.

Patananan A, Sercel A, Wu T, Ahsan F, Torres Jr A, Kennedy S . Pressure-Driven Mitochondrial Transfer Pipeline Generates Mammalian Cells of Desired Genetic Combinations and Fates. Cell Rep. 2020; 33(13):108562. PMC: 7927156. DOI: 10.1016/j.celrep.2020.108562. View